Shares of Acadia Healthcare Company Inc (NASDAQ:ACHC) have been given an average recommendation of “Buy” by the sixteen analysts that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and ten have assigned a buy recommendation to the company. The average 12-month target price among analysts that have covered the stock in the last year is $44.77.
ACHC has been the topic of a number of recent research reports. BidaskClub cut Acadia Healthcare from a “buy” rating to a “hold” rating in a report on Friday, June 1st. ValuEngine cut Acadia Healthcare from a “sell” rating to a “strong sell” rating in a report on Friday, June 29th. Credit Suisse Group raised their target price on Acadia Healthcare from $40.00 to $44.00 and gave the stock a “neutral” rating in a report on Tuesday, July 31st. Finally, BMO Capital Markets cut Acadia Healthcare from an “outperform” rating to a “market perform” rating and set a $45.00 target price on the stock. in a report on Wednesday, August 1st.
Shares of NASDAQ ACHC traded up $0.02 during midday trading on Monday, hitting $40.02. 11,898 shares of the stock traded hands, compared to its average volume of 512,914. The stock has a market capitalization of $3.67 billion, a price-to-earnings ratio of 17.44, a PEG ratio of 1.49 and a beta of 0.62. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.24 and a quick ratio of 1.24. Acadia Healthcare has a one year low of $26.92 and a one year high of $49.05.
Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Monday, July 30th. The company reported $0.70 earnings per share for the quarter, meeting the consensus estimate of $0.70. The firm had revenue of $765.70 million for the quarter, compared to analysts’ expectations of $767.93 million. Acadia Healthcare had a return on equity of 7.93% and a net margin of 7.52%. The company’s revenue was up 5.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.66 EPS. equities research analysts anticipate that Acadia Healthcare will post 2.52 EPS for the current year.
In other Acadia Healthcare news, Director Reeve B. Waud sold 8,135 shares of the firm’s stock in a transaction dated Thursday, July 26th. The stock was sold at an average price of $45.00, for a total transaction of $366,075.00. Following the sale, the director now directly owns 14,213 shares of the company’s stock, valued at $639,585. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 11.10% of the stock is owned by company insiders.
A number of large investors have recently bought and sold shares of ACHC. Alpine Woods Capital Investors LLC bought a new stake in Acadia Healthcare during the second quarter valued at about $153,000. New Jersey Better Educational Savings Trust bought a new stake in Acadia Healthcare during the second quarter valued at about $205,000. Cubist Systematic Strategies LLC purchased a new position in shares of Acadia Healthcare during the first quarter valued at about $255,000. Bbva Compass Bancshares Inc. purchased a new position in shares of Acadia Healthcare during the second quarter valued at about $259,000. Finally, BNP Paribas Arbitrage SA grew its position in shares of Acadia Healthcare by 118.3% during the second quarter. BNP Paribas Arbitrage SA now owns 8,425 shares of the company’s stock valued at $345,000 after purchasing an additional 4,566 shares in the last quarter.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.
Featured Story: What is a Leveraged Buyout (LBO)?
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.